Literature DB >> 90109

Type-specific binding antibody to baboon endogenous virus (M7) reverse transcriptase.

M Robert-Gurof, R C Gallo.   

Abstract

A type-specific binding antibody to the baboon endogenous virus, M7, reverse transcriptase was developed and characterized using a double antibody immunoprecipitation assay. This assay allows the analysis of non-enzyme neutralizing binding antibody, as well as the detection of early antibody production before high titre enzyme neutralizing antibodies appear. The antibody described is unique among hyperimmune antisera to DNA polymerases in that it recognizes only type-specific determinants on the enzyme molecule. Analysis of the enzymes of several BaEV isolates indicated a grouping of those from Papio cynocephalus, P. anubis and the HL23VBab isolate. The RD-114 enzyme was in a separate class, and the P. papio and P. hamadryas DNA polymerases were distinguished from all the other BaEV enzymes but not from each other.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90109     DOI: 10.1099/0022-1317-43-1-241

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus.

Authors:  K Sano; M H Lee; F Morales; P Nishanian; J Fahey; R Detels; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

2.  Comparative analysis: intracellular precursor polyproteins of baboon endogenous retroviruses and human viral isolate HL23V.

Authors:  S A Whiteley; R B Naso
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

3.  Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay.

Authors:  T Urabe; K Sano; T Nakano; F Odawara; M H Lee; T Otake; S Okubo; M Hayami; H Misaki; M Baba
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.